SARA POSLAIKO: Open Payments
NPI 1629693734 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 11 payments from 10 companies in 2025. Trend: 2023 $426 · 2024 $600 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $124 |
| Boston Scientific Corporation | 1 | $51 |
| LeMaitre Vascular, Inc. | 1 | $25 |
| CORDIS US CORP. | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| MIMEDX Group, Inc. | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $14 |
Products named: VENASEAL, Kerendia, ANNOVERA, MOUNJARO, ENROUTE Transcarotid Stent, XENOSURE BIOLOGIC PATCH, S.M.A.R.T., Ozempic.
Industry payments across FL — which companies pay providers there.
